Glenmark Pharma Q3 PAT rises 21.3% to Rs 290.8 crore
Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.
Latest News from Moneycontrol.com
Building Self-Control Through Mindful Practices
Understanding The Importance Of Financial Habits

